{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:52:49Z","timestamp":1761562369271,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.carrev.2018.08.006","type":"journal-article","created":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T04:29:41Z","timestamp":1534220981000},"page":"812-813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PB","title":["Closure of the patent foramen ovale stepping out of the Cinderella role"],"prefix":"10.1016","volume":"19","author":[{"given":"Bernhard","family":"Meier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Nietlispach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2018.08.006_bb0005","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.carrev.2018.02.014","article-title":"Percutaneous closure of patent foramen ovale vs. medical treatment for patients with history of cryptogenic stroke: a systematic review and meta-analysis of randomized controlled trials","volume":"19","author":"Palaiodimos","year":"2018","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2018.08.006_bb0010","article-title":"Cryptogenic stroke and patent foramen ovale: ready for prime time?","author":"Mojadidi","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2018.08.006_bb0015","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.jacc.2018.02.046","article-title":"Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial","volume":"71","author":"Lee","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2018.08.006_bb0020","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1093\/eurheartj\/ehy134","article-title":"The Evil of the patent foramen ovale: we are seeing but the tip of the iceberg","volume":"39","author":"Meier","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2018.08.006_bb0025","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/CIRCULATIONAHA.111.030494","article-title":"Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism","volume":"125","author":"Wahl","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2018.08.006_bb0030","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(07)61745-0","article-title":"Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study","volume":"370","author":"Sorensen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2018.08.006_bb0035","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1161\/01.CIR.97.19.1946","article-title":"Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism","volume":"97","author":"Konstantinides","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2018.08.006_bb0040","first-page":"354","article-title":"Offenes Foramen ovale: Gute Gr\u00fcnde es zu verschliessen","volume":"43","author":"Meier","year":"2018","journal-title":"Dtsch Med Wochenschr"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838918303580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838918303580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:14:20Z","timestamp":1761560060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838918303580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1553838918303580"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2018.08.006","relation":{},"ISSN":["1553-8389"],"issn-type":[{"type":"print","value":"1553-8389"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Closure of the patent foramen ovale stepping out of the Cinderella role","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2018.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}